Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
靶向BCMA或GPRC5D的双特异性抗体在CAR-T细胞疗法后复发的多发性骨髓瘤中疗效显著。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01197-2
Merz, Maximilian; Dima, Danai; Hashmi, Hamza; Ahmed, Nausheen; Stölzel, Friedrich; Holderried, Tobias A W; Fenk, Roland; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Rathje, Kristin; Davis, James A; Fandrei, David; Vucinic, Vladan; Kharboutli, Soraya; Baermann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Albici, Anca-Maria; Schub, Nathalie; Schmitz, Friederike; Shune, Leyla; Khouri, Jack; Anwer, Faiz; Raza, Shahzad; McGuirk, Joseph; Mahmoudjafari, Zahra; Green, Kimberly; Khandanpour, Cyrus; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; von Tresckow, Bastian; de Larrea, Carlos Fernández; Pabst, Thomas; Abdallah, Al-Ola; Gagelmann, Nico
T细胞
多发性骨髓瘤
T细胞
骨髓瘤
细胞生物学
免疫/内分泌